4//SEC Filing
Wilson Marc 4
Accession 0000950170-24-080557
CIK 0001658247other
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 4:32 PM ET
Size
8.9 KB
Accession
0000950170-24-080557
Insider Transaction Report
Form 4
Wilson Marc
CFO
Transactions
- Sale
Common Stock
2024-06-28$43.61/sh−32,129$1,401,146→ 111,092 total - Exercise/Conversion
Stock option (Right to Buy)
2024-06-28−32,129→ 19,056 totalExercise: $9.28Exp: 2028-05-24→ Common Stock (32,129 underlying) - Exercise/Conversion
Common Stock
2024-06-28$9.28/sh+32,129$298,157→ 143,221 total
Footnotes (4)
- [F1]The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sales price of $43.61 per share. The range of sales prices on the transaction date was $43.28 to $44.13 per share. Detailed information on the exact number of shares can be obtained from the issuer upon request.
- [F3]Includes 462 shares acquired under the Issuer's Employee Stock Purchase Plan.
- [F4]1/48th of the shares subject to the option vested on June 25, 2018, and 1/48th of the shares subject to the option vest monthly thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.
Documents
Issuer
Crinetics Pharmaceuticals, Inc.
CIK 0001658247
Entity typeother
Related Parties
1- filerCIK 0001702265
Filing Metadata
- Form type
- 4
- Filed
- Jul 1, 8:00 PM ET
- Accepted
- Jul 2, 4:32 PM ET
- Size
- 8.9 KB